# info@crystallizationsummit.com

Blog Details

Dr. Susan M. Reutzel-Edens

Dr. Susan M. Reutzel-Edens, President of SuRE Pharma Consulting, LLC, earned her Ph.D. in Chemistry at the University of Minnesota under the direction of the late Professor Margaret C. Etter. Over nearly 30 years at Eli Lilly and Company, she led a team of cross-functional scientists charged with finding commercially-viable crystalline forms for small-molecule drug products and served in a strategic scientific leadership role championing R&D innovation across the Small Molecule Design & Development organization. In 2021, she joined the Executive Leadership Team of the Cambridge Crystallographic Data Centre, where for two years she provided strategic scientific oversight of R&D innovation as Head of Science.
Susan has contributed to the development of more than 150 compounds, is a named inventor on 12 US patents, and has published over 60 papers and book chapters on key aspects of solid form development. Her research interests span diverse topics in organic solid-state chemistry and pharmaceutical materials science, including polymorphism, materials design and engineering, crystallization, solid form screening, physical characterization, structure-property relationships, crystal structure prediction and digital design. She was elected Fellow of the Royal Society of Chemistry in 2018, and currently serves on the CrystEngComm Editorial Board, the Editorial Advisory Boards of Journal of Pharmaceutical Sciences, Molecular Pharmaceutics, and Pharmaceutical Research, and as a topic editor for Crystal Growth and Design. She also served on the inaugural Scientific Advisory Board of the Cambridge Crystallographic Data Centre and is an adjunct professor in the Industrial and Molecular Pharmaceutics Department at Purdue University.
RSS
Follow by Email
LinkedIn
Share